KALA (Kala Bio) 3-1 Month Momentum %: -73.90% (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KALA Kala Bio Inc KALA
21 GF Score
Price $0.82
! 1 Warning Sign
View Full Analysis

What is Kala Bio 3-1 Month Momentum %?

Kala Bio KALA +3.22% 21 3-1 Month Momentum % is -73.90% as of Aug. 26, 2026. GuruFocus rates KALA with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 1,389 Biotechnology companies, Kala Bio ranks worse than 98.99% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-26), Kala Bio's 3-1 Month Momentum % is -73.90%.

The industry rank for Kala Bio's 3-1 Month Momentum % or its related term are showing as below:

KALA's 3-1 Month Momentum % is ranked worse than
98.99% of 1389 companies
in the Biotechnology industry
Industry Median: -9.31 vs KALA: -73.90

Kala Bio  (NAS:KALA) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Kala Bio 3-1 Month Momentum % Related Terms

KALA vs GDTC, GTBP, INAB: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, Kala Bio's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kala Bio 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kala Bio's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Kala Bio's 3-1 Month Momentum % falls into.


KALA
21GF Score
Kala Bio Inc KALA
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kala Bio  (NAS:KALA) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -73.90% mean?
Kala Bio (KALA) has a 3-1 Month Momentum % of -73.90% as of Aug. 26, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Kala Bio and its competitors. According to the industry distribution chart, Kala Bio ranks #1375 out of 1389 companies in the Biotechnology industry, placing it in the top 99%.
Is Kala Bio's 3-1 Month Momentum % too high?
Kala Bio's current 3-1 Month Momentum % is -73.90%. Based on the distribution chart, Kala Bio ranks #1375 out of 1389 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Kala Bio has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Kala Bio's 3-1 Month Momentum % compare to GDTC and GTBP?
According to the Biotechnology industry distribution chart, Kala Bio ranks #1375 out of 1389 companies for 3-1 Month Momentum %. This places Kala Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
A good 3-1 Month Momentum % depends on the Biotechnology industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Kala Bio and its competitors. Kala Bio's current 3-1 Month Momentum % is -73.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kala Bio stock overvalued right now?
Kala Bio (KALA) has a current 3-1 Month Momentum % of -73.90%. The current 3-1 Month Momentum % is -73.90%. Kala Bio's overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Kala Bio (KALA), the current 3-1 Month Momentum % is -73.90% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kala Bio Business Description

Other Exchanges 0JQ2:UK27F:Germany
Address 1167 Massachusetts Avenue, Arlington, MA, USA, 02476
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
21GF Score

Get the complete analysis for KALA

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.82
Price